About GenPAx
GenPAx is a biotechnology company enabling next-generation precision medicine to fight pathogens. GenPAx will provide fast, high definition, affordable data analysis of bacteria genome sequence data globally. GenPAx aims to provide clinics, laboratories, and hospitals with vital infection control information in order to derive solutions to contain, treat and eradicate threats to mankind.
Founded in 2021 by Julian Hardy and Nigel Saunders.
- Founded
- 2021
- Employees
- 1 to 10
- Total funding
- $2.7M
- Headquarters
- Saanen
Leadership
The top of GenPAx's org chart, with how many people report into each leader.
Nigel Saunders MBChB PhD
Chief Scientific Officer GENPAX
8 reports
Ray Schaaf
President, Inc.
2 reports
Alex Mitchell
Director Of Bioinformatics
7 reports
Shannon Rapp
VP, Finance & HR
1 report
Jobs at GenPAx
No open positions right now. Explore more companies on TheJobsMap.